Encyclopedia of Cancer

Living Edition
| Editors: Manfred Schwab

Eph Receptors

  • Diego Arango
Living reference work entry
DOI: https://doi.org/10.1007/978-3-642-27841-9_1928-2


Eph receptors are tyrosine kinases (RTK) bound to the extracellular membrane that function as “switches” that upon activation by ephrin (EFN) ligands initiate signaling cascades that regulate numerous developmental processes, particularly in the vasculature and nervous system.


The name of the Eph receptors is derived from the name of the cell line used to characterize them initially (erythropoietin-producing hepatocellular carcinoma cell line). These receptors and their ephrin (EFN) ligands constitute the largest family of receptor tyrosine kinases (RTK)known to date. Eph receptors are integral membrane proteins with a conserved N-terminal domain responsible for ligand binding, followed by a cysteine-rich region and two fibronectin type III repeats which are essential for dimerization and interactions with other proteins. The intracellular region of these receptors contains a juxtamembrane domain, a conserved kinase domain, a sterile alpha motif (SAM), and...


Focal Adhesion Kinase Cytoskeleton Organization Sterile Alpha Motif EphB Receptor Important Tumor Suppressor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.


  1. Alazzouzi H, Davalos V, Kokko A et al (2005) Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors. Cancer Res 65:10170–10173CrossRefPubMedGoogle Scholar
  2. Committee EN (1997) Unified nomenclature for Eph family receptors and their ligands, the ephrins, Eph Nomenclature Committee. Cell 90:403–404CrossRefGoogle Scholar
  3. Davalos V, Dopeso H, Castano J et al (2006) EPHB4 and survival of colorectal cancer patients. Cancer Res 66:8943–8948CrossRefPubMedGoogle Scholar
  4. Holder N, Klein R (1996) Eph receptors and ephrins: effectors of morphogenesis. Development 126:2033–2044Google Scholar
  5. Surawska H, Ma PC, Salgia R (2004) The role of ephrins and Eph receptors in cancer. Cytokine Growth Factor Rev 15:419–433CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2015

Authors and Affiliations

  1. 1.CIBBIM - Nanomedicina Oncologia MolecularVall d’Hebron Hospital Research InstituteBarcelonaSpain